Multicenter, randomized, double-blind, placebo controlled, parallel group trial to evaluate the effect of Vitamin D supplementation for fall prevention

Multicenter, randomized, double-blind, placebo controlled, parallel group trial to evaluate the effect of Vitamin D supplementation for fall prevention - Effect of Vitamin D supplementation for fall prevention

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008361

Enrollment

220

Registered

2012-07-06

Start date

2013-01-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fall

Interventions

Beverage contained Vitamin D supplement (liquid) 1 drop/day (1,000IU) 1 year(52 weeks) Placebo beverage without Vitamin D supplement 1 year(52 weeks)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Residents in the social welfare corporation kensyokai associated facilities

Exclusion criteria

Exclusion criteria: History of kidney stones or ureterolithiasis. Clinically significant hepatic, cardiac, or renal insufficiency Hypercalcemia Malabsorption syndrome Consumption of medications known to interfere with vitamin D metabolism History of hypersensitivity reactions to vitamin D Any other conditions deemed unsuitable for trial as evaluated by the physician-in-charge Subject who refuse to participate in this study

Design outcomes

Primary

Measure	Time frame
Efficacy of fall prevention	—

Secondary

Measure	Time frame
Physical function Fracture incidence Cognitive function Mental examination (modified falls efficacy scale) Blood test	—

Countries

Japan

Contacts

Public ContactTetsuya Enishi

Tokushima university Division of Rehabilitation, Tokushima University Hospital

enishi.tetsuya@tokushima-u.ac.jp088-633-7240

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026